270 related articles for article (PubMed ID: 17445439)
21. Increased excretion of urinary podocytes in lupus nephritis.
Bollain-Y-Goytia JJ; González-Castañeda M; Torres-Del-Muro F; Daza-Benitez L; Zapata-Benavides P; Rodríguez-Padilla C; Avalos-Díaz E; Herrera-Esparza R
Indian J Nephrol; 2011 Jul; 21(3):166-71. PubMed ID: 21886975
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of plasmapheresis and intravenous cyclophosphamide on urinary podocyte excretion in patients with proliferative Lupus nephritis.
Nakamura T; Ushiyama C; Hara M; Osada S; Ugai K; Shimada N; Hayashi K; Ebihara I; Koide H
Clin Nephrol; 2002 Feb; 57(2):108-13. PubMed ID: 11863119
[TBL] [Abstract][Full Text] [Related]
23. [Significance of detecting urinary podocytes in patients with active glomerulonephritis].
Li JZ; Huang HC; Liu Y; E J
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):463-6. PubMed ID: 16224513
[TBL] [Abstract][Full Text] [Related]
24. Renal biopsy findings in new-onset systemic lupus erythematosus with clinical renal disease.
Wen YK
Int Urol Nephrol; 2011 Sep; 43(3):801-6. PubMed ID: 21336956
[TBL] [Abstract][Full Text] [Related]
25. Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis.
Wang G; Lai FM; Tam LS; Li KM; Lai KB; Chow KM; Li KT; Szeto CC
J Rheumatol; 2007 Dec; 34(12):2358-64. PubMed ID: 17985404
[TBL] [Abstract][Full Text] [Related]
26. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy.
Kodama F; Asanuma K; Takagi M; Hidaka T; Asanuma E; Fukuda H; Seki T; Takeda Y; Hosoe-Nagai Y; Asao R; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2013 Jul; 28(7):1762-72. PubMed ID: 23143340
[TBL] [Abstract][Full Text] [Related]
27. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
Rezende GM; Viana VS; Malheiros DM; Borba EF; Silva NA; Silva C; Leon EP; Noronha IL; Bonfa E
Lupus; 2014 Mar; 23(3):255-62. PubMed ID: 24356611
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
[TBL] [Abstract][Full Text] [Related]
29. Assessment of detached podocytes in the Bowman's space as a marker of disease activity in lupus nephritis.
Moustafa FE; Soliman NA; Bakr AM; El Shwaf IM
Lupus; 2014 Feb; 23(2):146-50. PubMed ID: 24306541
[TBL] [Abstract][Full Text] [Related]
30. Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis.
Bouachi K; Moktefi A; Zhang SY; Oniszczuk J; Sendeyo K; Remy P; Audard V; Pawlak A; Ollero M; Sahali D
PLoS One; 2018; 13(11):e0207066. PubMed ID: 30439969
[TBL] [Abstract][Full Text] [Related]
31. Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.
Wang G; Lai FM; Tam LS; Li EK; Kwan BC; Chow KM; Li PK; Szeto CC
Rheumatology (Oxford); 2009 Jul; 48(7):755-60. PubMed ID: 19458162
[TBL] [Abstract][Full Text] [Related]
32. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
Ma R; Jiang W; Li Z; Sun Y; Wei Z
Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
[TBL] [Abstract][Full Text] [Related]
33. Detection of podocyturia in patients with lupus nephritis.
Sabino AR; Teixeira Vde P; Nishida SK; Sass N; Mansur JB; Kirsztajn GM
J Bras Nefrol; 2013; 35(4):252-8. PubMed ID: 24402104
[TBL] [Abstract][Full Text] [Related]
34. A new morphologic index for the evaluation of renal biopsies in lupus nephritis.
Hill GS; Delahousse M; Nochy D; Tomkiewicz E; Rémy P; Mignon F; Méry JP
Kidney Int; 2000 Sep; 58(3):1160-73. PubMed ID: 10972679
[TBL] [Abstract][Full Text] [Related]
35. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
[TBL] [Abstract][Full Text] [Related]
36. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
37. Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis.
Chen S; Tang Z; Zhang Y; Liu Z; Zhang H; Hu W; Liu Z
Am J Nephrol; 2013; 38(6):445-52. PubMed ID: 24247741
[TBL] [Abstract][Full Text] [Related]
38. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.
Hill GS; Delahousse M; Nochy D; Bariéty J
Kidney Int; 2005 Nov; 68(5):2288-97. PubMed ID: 16221231
[TBL] [Abstract][Full Text] [Related]
39. Glomerular macrophage is an indicator of early treatment response in diffuse proliferative lupus nephritis.
Cheunsuchon B; Incharoen P; Chawanasuntorapoj R; Chanchairujira T; Shayakul C
J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S246-51. PubMed ID: 23590049
[TBL] [Abstract][Full Text] [Related]
40. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
Cai X; Yang X; Lian F; Lin X; Liang M; Li J; Chen X; Liang L; Qin S; Fu J
J Rheumatol; 2010 Apr; 37(4):759-65. PubMed ID: 20194446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
